Tango Therapeutics Revenue vs. Shares Owned By Insiders

TNGX Stock  USD 3.10  0.16  5.44%   
Based on Tango Therapeutics' profitability indicators, Tango Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Tango Therapeutics' ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
36.5 M
Current Value
28.8 M
Quarterly Volatility
6.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Tango Therapeutics' Days Sales Outstanding is fairly stable compared to the past year. Days Of Sales Outstanding is likely to rise to 52.95 in 2024, whereas Price To Sales Ratio is likely to drop 19.37 in 2024. At this time, Tango Therapeutics' Accumulated Other Comprehensive Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 13.2 M in 2024, despite the fact that Operating Income is likely to grow to (108.5 M).
For Tango Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tango Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tango Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tango Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tango Therapeutics over time as well as its relative position and ranking within its peers.
  

Tango Therapeutics' Revenue Breakdown by Earning Segment

Check out World Market Map.
For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tango Therapeutics. If investors know Tango will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tango Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.402
Quarterly Revenue Growth
0.082
Return On Assets
(0.22)
Return On Equity
(0.49)
The market value of Tango Therapeutics is measured differently than its book value, which is the value of Tango that is recorded on the company's balance sheet. Investors also form their own opinion of Tango Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tango Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tango Therapeutics' market value can be influenced by many factors that don't directly affect Tango Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tango Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tango Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tango Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tango Therapeutics Shares Owned By Insiders vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Tango Therapeutics's current stock value. Our valuation model uses many indicators to compare Tango Therapeutics value to that of its competitors to determine the firm's financial worth.
Tango Therapeutics is rated fourth in revenue category among its peers. It is rated fifth in shares owned by insiders category among its peers . The ratio of Revenue to Shares Owned By Insiders for Tango Therapeutics is about  2,844,782 . At this time, Tango Therapeutics' Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tango Therapeutics' earnings, one of the primary drivers of an investment's value.

Tango Revenue vs. Competition

Tango Therapeutics is rated fourth in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 353.9 Million. Tango Therapeutics retains roughly 36.53 Million in revenue claiming about 10% of equities under Health Care industry.

Tango Shares Owned By Insiders vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Tango Therapeutics

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
36.53 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Tango Therapeutics

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
12.84 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Tango Shares Owned By Insiders Comparison

Tango Therapeutics is currently under evaluation in shares owned by insiders category among its peers.

Tango Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Tango Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tango Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Tango Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Tango Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income186 K195.3 K
Operating Income-114.2 M-108.5 M
Income Before Tax-101.6 M-106.7 M
Total Other Income Expense Net12.6 M13.2 M
Net Loss-97.4 M-92.5 M
Net Loss-101.7 M-106.8 M
Net Interest IncomeM5.2 M
Interest IncomeM5.2 M
Net Loss-100 M-105 M
Income Tax Expense134 K102.3 K
Non Operating Income Net Other-1.3 M-1.4 M
Change To Netincome15.6 M16.4 M
Net Loss(1.08)(1.13)
Income Quality 1.16  1.22 
Net Income Per E B T 1.00  0.80 

Tango Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Tango Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tango Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tango Therapeutics' important profitability drivers and their relationship over time.

Use Tango Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tango Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tango Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Tango Therapeutics Pair Trading

Tango Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Tango Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tango Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tango Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tango Therapeutics to buy it.
The correlation of Tango Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tango Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tango Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tango Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Tango Therapeutics position

In addition to having Tango Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Machinery Thematic Idea Now

Machinery
Machinery Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Machinery theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Machinery Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.